Skip to main content
. 2021 Feb 20;185:114485. doi: 10.1016/j.bcp.2021.114485

Fig. 1.

Fig. 1

Structure and efficacy of TDF and TAF monotherapy in the HBV treatment. (a) TDF and TAF are the prodrugs of tenofovir. (b) Clinical efficacy of TDF and TDF in HBV-infected patients treated with either adefovir dipivoxil 10 mg or TDF 300 mg, TAF 25 mg. Efficacy data from phase 3 or 4 trials were summarized in Table 2.